Dimensional Fund Advisors LP Has $115.62 Million Stock Position in Maximus, Inc. $MMS

Key Points

• Dimensional Fund Advisors LP increased its stake in Maximus, Inc. by 20.5% during the first quarter, holding 1,695,582 shares valued at approximately $115.6 million.
• Maximus reported earnings of $2.16 per share for the last quarter, exceeding analyst expectations and showing a 2.5% increase in revenue year-over-year.
• The company announced a $0.30 quarterly dividend to be paid on August 31st, with an annualized yield of 1.4%.

Dimensional Fund Advisors LP grew its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 20.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 1,695,582 shares of the health services provider's stock after buying an additional 288,990 shares during the period. Dimensional Fund Advisors LP owned 3.00% of Maximus worth $115,620,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in MMS. SG Capital Management LLC purchased a new stake in Maximus during the fourth quarter worth about $30,285,000. Reinhart Partners LLC. boosted its position in shares of Maximus by 65.4% in the first quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock worth $62,156,000 after acquiring an additional 360,365 shares during the last quarter. Boston Partners acquired a new stake in shares of Maximus during the 1st quarter worth $20,983,000. Squarepoint Ops LLC acquired a new stake in Maximus during the fourth quarter worth about $22,661,000. Finally, Voloridge Investment Management LLC increased its stake in Maximus by 306.8% during the fourth quarter. Voloridge Investment Management LLC now owns 376,055 shares of the health services provider's stock worth $28,073,000 after acquiring an additional 283,608 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Analysts Set New Price Targets

Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $90.00.

Maximus Stock Performance

MMS stock traded down $1.0940 during midday trading on Monday, reaching $85.9060. The company had a trading volume of 457,306 shares, compared to its average volume of 651,893. The stock has a 50 day moving average price of $74.84 and a 200 day moving average price of $71.16. The firm has a market capitalization of $4.84 billion, a PE ratio of 15.82 and a beta of 0.60. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter in the previous year, the company posted $1.74 earnings per share. The business's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, August 15th. Maximus's dividend payout ratio (DPR) is presently 22.10%.

Insiders Place Their Bets

In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the sale, the director directly owned 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.